EBITDA Margin (Annual)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

HealthEquity, Inc. (HQY) had EBITDA Margin of 36.41% for the most recently reported fiscal year, ending 2026-01-31.

Quarterly Annual

Figures for fiscal year ending 2026-01-31

Income Statement Financials
Revenue	$1.31B
Net Income	$215.20M
Cost of Goods Sold	$400.31M
Gross Profit	$913.12M
Operating Expenses	$990.97M
Operating Income	$322.46M
Non-Operating Income/Expense	$-45.02M
Pre-Tax Income	$277.43M
Normalized Pre-Tax Income	$277.43M
Income after Taxes	$215.20M
Income from Continuous Operations	$215.20M
Consolidated Net Income/Loss	$215.20M
Normalized Income after Taxes	$215.20M
EBIT	$322.46M
EBITDA	$478.18M
Weighted-Average Shares Outstanding (Basic)	86.13M
Weighted-Average Shares Outstanding (Diluted)	87.47M
Earnings per Share (EPS) (Basic)	$2.50
Earnings per Share (EPS) (Diluted)	$2.46
Balance Sheet Financials
Current Assets	$512.28M
Property, Plant, and Equipment	$3.18M
Long-Term Assets	$2.87B
Total Assets	$3.38B
Current Liabilities	$156.85M
Long-Term Debt	$957.38M
Long-Term Liabilities	$1.12B
Total Liabilities	$1.27B
Common Equity	$2.11B
Tangible Shareholders Equity	$-638.12M
Shareholders Equity	$2.11B
Common Shares Outstanding	85.01M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$457.09M
Cash Flow from Investing Activities	$-47.14M
Cash Flow from Financial Activities	$-386.98M
Beginning Cash	$295.95M
End Cash	$318.93M
Increase/Decrease in Cash	$22.98M
Stock-Based Compensation	$73.06M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.31
Debt to Equity Ratio	0.45
Gross Margin	69.52%
Operating Margin	24.55%
EBIT Margin	24.55%
EBITDA Margin	36.41%
Pre-Tax Profit Margin	21.12%
Profit Margin	16.38%
Free Cash Flow	$408.61M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	--
Receiveable Turnover	10.62
Days Sales in Receivables	34.37
Return on Equity	10.21%
Return on Tangible Equity	-33.72%
Return on Assets	6.37%
Return on Investments	7.02%
Book Value Per Share	$24.79
Free Cash Flow per Share	$4.67
Operating Cash Flow per Share	$5.23

Data from Zacks Investment Research, Inc.